These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 22809628
1. Distinct roles of AKT isoforms in regulating β1-integrin activity, migration, and invasion in prostate cancer. Virtakoivu R, Pellinen T, Rantala JK, Perälä M, Ivaska J. Mol Biol Cell; 2012 Sep; 23(17):3357-69. PubMed ID: 22809628 [Abstract] [Full Text] [Related]
2. AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins. Riggio M, Perrone MC, Polo ML, Rodriguez MJ, May M, Abba M, Lanari C, Novaro V. Sci Rep; 2017 Mar 13; 7():44244. PubMed ID: 28287129 [Abstract] [Full Text] [Related]
3. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway. Meng Q, Xia C, Fang J, Rojanasakul Y, Jiang BH. Cell Signal; 2006 Dec 13; 18(12):2262-71. PubMed ID: 16839745 [Abstract] [Full Text] [Related]
4. AKT isoforms 1 and 3 regulate basal and epidermal growth factor-stimulated SGHPL-5 trophoblast cell migration in humans. Haslinger P, Haider S, Sonderegger S, Otten JV, Pollheimer J, Whitley G, Knöfler M. Biol Reprod; 2013 Mar 13; 88(3):54. PubMed ID: 23303682 [Abstract] [Full Text] [Related]
5. Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgen-independent prostate cancer cells. Cariaga-Martinez AE, López-Ruiz P, Nombela-Blanco MP, Motiño O, González-Corpas A, Rodriguez-Ubreva J, Lobo MV, Cortés MA, Colás B. Cell Signal; 2013 Jul 13; 25(7):1586-97. PubMed ID: 23567263 [Abstract] [Full Text] [Related]
6. Roles of AKT1 and AKT2 in non-small cell lung cancer cell survival, growth, and migration. Lee MW, Kim DS, Lee JH, Lee BS, Lee SH, Jung HL, Sung KW, Kim HT, Yoo KH, Koo HH. Cancer Sci; 2011 Oct 13; 102(10):1822-8. PubMed ID: 21722267 [Abstract] [Full Text] [Related]
7. Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4. Grottke A, Ewald F, Lange T, Nörz D, Herzberger C, Bach J, Grabinski N, Gräser L, Höppner F, Nashan B, Schumacher U, Jücker M. PLoS One; 2016 Oct 13; 11(1):e0146370. PubMed ID: 26741489 [Abstract] [Full Text] [Related]
8. Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells. Grabinski N, Bartkowiak K, Grupp K, Brandt B, Pantel K, Jücker M. Cell Signal; 2011 Dec 13; 23(12):1952-60. PubMed ID: 21777670 [Abstract] [Full Text] [Related]
9. Implication of Integrin α2β1 in Proliferation and Invasion of Human Breast Carcinoma and Melanoma Cells: Noncanonical Function of Akt Protein Kinase. Kozlova NI, Morozevich GE, Ushakova NA, Berman AE. Biochemistry (Mosc); 2018 Jun 13; 83(6):738-745. PubMed ID: 30195330 [Abstract] [Full Text] [Related]
10. Receptor-specific mechanisms regulate phosphorylation of AKT at Ser473: role of RICTOR in β1 integrin-mediated cell survival. Riaz A, Zeller KS, Johansson S. PLoS One; 2012 Jun 13; 7(2):e32081. PubMed ID: 22384145 [Abstract] [Full Text] [Related]
11. Resistance to the mTOR-inhibitor RAD001 elevates integrin α2- and β1-triggered motility, migration and invasion of prostate cancer cells. Tsaur I, Makarević J, Juengel E, Gasser M, Waaga-Gasser AM, Kurosch M, Reiter M, Wedel S, Bartsch G, Haferkamp A, Wiesner C, Blaheta RA. Br J Cancer; 2012 Aug 21; 107(5):847-55. PubMed ID: 22782340 [Abstract] [Full Text] [Related]
12. Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Arboleda MJ, Lyons JF, Kabbinavar FF, Bray MR, Snow BE, Ayala R, Danino M, Karlan BY, Slamon DJ. Cancer Res; 2003 Jan 01; 63(1):196-206. PubMed ID: 12517798 [Abstract] [Full Text] [Related]
13. Involvement of Akt isoforms in chemoresistance of endometrial carcinoma cells. Girouard J, Lafleur MJ, Parent S, Leblanc V, Asselin E. Gynecol Oncol; 2013 Feb 01; 128(2):335-43. PubMed ID: 23174537 [Abstract] [Full Text] [Related]
14. Loss of Akt1 or Akt2 delays mammary tumor onset and suppresses tumor growth rate in MTB-IGFIR transgenic mice. Watson KL, Moorehead RA. BMC Cancer; 2013 Aug 07; 13():375. PubMed ID: 23919516 [Abstract] [Full Text] [Related]
15. Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells. Häggblad Sahlberg S, Mortensen AC, Haglöf J, Engskog MK, Arvidsson T, Pettersson C, Glimelius B, Stenerlöw B, Nestor M. Int J Oncol; 2017 Jan 07; 50(1):5-14. PubMed ID: 27878243 [Abstract] [Full Text] [Related]
16. Selective activation of Akt1 by mammalian target of rapamycin complex 2 regulates cancer cell migration, invasion, and metastasis. Kim EK, Yun SJ, Ha JM, Kim YW, Jin IH, Yun J, Shin HK, Song SH, Kim JH, Lee JS, Kim CD, Bae SS. Oncogene; 2011 Jun 30; 30(26):2954-63. PubMed ID: 21339740 [Abstract] [Full Text] [Related]
17. The role of AKT isoforms in glioblastoma: AKT3 delays tumor progression. Joy A, Kapoor M, Georges J, Butler L, Chang Y, Li C, Crouch A, Smirnov I, Nakada M, Hepler J, Marty M, Feuerstein BG. J Neurooncol; 2016 Oct 30; 130(1):43-52. PubMed ID: 27422127 [Abstract] [Full Text] [Related]
18. Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism. Zhang HF, Alshareef A, Wu C, Li S, Jiao JW, Cao HH, Lai R, Xu LY, Li EM. Oncotarget; 2015 Oct 06; 6(30):28949-60. PubMed ID: 26334393 [Abstract] [Full Text] [Related]
19. Knockdown of Akt isoforms by RNA silencing suppresses the growth of human prostate cancer cells in vitro and in vivo. Sasaki T, Nakashiro K, Tanaka H, Azuma K, Goda H, Hara S, Onodera J, Fujimoto I, Tanji N, Yokoyama M, Hamakawa H. Biochem Biophys Res Commun; 2010 Aug 13; 399(1):79-83. PubMed ID: 20638364 [Abstract] [Full Text] [Related]
20. The plasma membrane sialidase NEU3 regulates the malignancy of renal carcinoma cells by controlling β1 integrin internalization and recycling. Tringali C, Lupo B, Silvestri I, Papini N, Anastasia L, Tettamanti G, Venerando B. J Biol Chem; 2012 Dec 14; 287(51):42835-45. PubMed ID: 23139422 [Abstract] [Full Text] [Related] Page: [Next] [New Search]